• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate.甲磺酸氟哌啶醇在十二烷基硫酸钠存在下的溶液介导的相转变。
AAPS PharmSciTech. 2011 Sep;12(3):909-16. doi: 10.1208/s12249-011-9656-4. Epub 2011 Jul 6.
2
Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug.溶液中盐的介稳相转变:以氟哌啶醇为模型药物的研究。
J Pharm Sci. 2011 Jul;100(7):2755-68. doi: 10.1002/jps.22507. Epub 2011 Feb 16.
3
Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.研究游离碱和两种不同盐形式的溶解度及溶出度随pH的变化情况。
Pharm Res. 2005 Apr;22(4):628-35. doi: 10.1007/s11095-005-2504-z. Epub 2005 Apr 7.
4
Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate.月桂基硫酸钠致利托那韦片溶出度降低的机制。
J Pharm Sci. 2019 Jan;108(1):516-524. doi: 10.1016/j.xphs.2018.10.047. Epub 2018 Oct 30.
5
Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion.月桂醇硫酸酯钠:烷基糖苷混合表面活性剂体系作为固体分散体载体的评估
AAPS PharmSciTech. 2008;9(2):583-90. doi: 10.1208/s12249-008-9093-1. Epub 2008 May 6.
6
Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.水不溶性药物体外测试的溶出介质:表面活性剂纯度和电解质对卡马西平在十二烷基硫酸钠水溶液中体外溶出的影响
J Pharm Sci. 1997 Mar;86(3):384-8. doi: 10.1021/js960105t.
7
Pharmaceutical Lauryl Sulfate Salts: Prevalence, Formation Rules, and Formulation Implications.药用月桂基硫酸盐盐:流行情况、形成规律和配方意义。
Mol Pharm. 2022 Feb 7;19(2):432-439. doi: 10.1021/acs.molpharmaceut.1c00690. Epub 2021 Oct 21.
8
The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol.酶和十二烷基硫酸钠对溶解介质表面张力的影响:深入理解卡维地洛的溶解度和溶解。
AAPS PharmSciTech. 2020 May 20;21(5):146. doi: 10.1208/s12249-020-01683-3.
9
Effect of sodium lauryl sulfate-mediated gelation on the suppressed dissolution of crystalline lurasidone hydrochloride and a strategy to mitigate the gelation.十二烷基硫酸钠致胶凝对盐酸鲁拉西酮结晶溶出抑制的影响及减轻胶凝的策略。
Int J Pharm. 2022 Aug 25;624:122035. doi: 10.1016/j.ijpharm.2022.122035. Epub 2022 Jul 19.
10
Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation.通过扩散层调节减轻月桂基硫酸钠对对氨基苯甲酸溶解减少的配方策略。
Int J Pharm. 2022 Jan 5;611:121310. doi: 10.1016/j.ijpharm.2021.121310. Epub 2021 Nov 22.

引用本文的文献

1
Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.探索过饱和和沉淀对难溶性药物口服生物利用度潜在影响的数学模型
AAPS J. 2015 Jul;17(4):902-17. doi: 10.1208/s12248-015-9748-2. Epub 2015 Apr 8.

本文引用的文献

1
Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug.溶液中盐的介稳相转变:以氟哌啶醇为模型药物的研究。
J Pharm Sci. 2011 Jul;100(7):2755-68. doi: 10.1002/jps.22507. Epub 2011 Feb 16.
2
Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques.层流流通式溶出仪的设计与特性:与常见溶出技术的流体动力学条件比较。
Pharm Dev Technol. 2011 Feb;16(1):75-87. doi: 10.3109/10837450903499341. Epub 2010 Jan 27.
3
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?超饱和药物递送系统:解决溶解度限制口服生物利用度的方法?
J Pharm Sci. 2009 Aug;98(8):2549-72. doi: 10.1002/jps.21650.
4
Salt formation to improve drug solubility.通过盐形成来提高药物溶解度。
Adv Drug Deliv Rev. 2007 Jul 30;59(7):603-16. doi: 10.1016/j.addr.2007.05.010. Epub 2007 May 29.
5
Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.使用戊二酸共晶体提高低溶解度活性药物成分的口服生物利用度。
Pharm Res. 2006 Aug;23(8):1888-97. doi: 10.1007/s11095-006-9032-3.
6
Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug.氯离子对典型碱性药物氟哌啶醇不同盐形式溶解的影响
J Pharm Sci. 2005 Oct;94(10):2224-31. doi: 10.1002/jps.20440.
7
Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.模拟空腹胃部环境及其对亲脂性化合物体内溶解的重要性。
Eur J Pharm Biopharm. 2005 Aug;60(3):413-7. doi: 10.1016/j.ejpb.2005.03.002.
8
Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.研究游离碱和两种不同盐形式的溶解度及溶出度随pH的变化情况。
Pharm Res. 2005 Apr;22(4):628-35. doi: 10.1007/s11095-005-2504-z. Epub 2005 Apr 7.
9
Effect of pH-sodium lauryl sulfate combination on solubilization of PG-300995 (an anti-HIV agent): a technical note.pH值与十二烷基硫酸钠组合对PG - 300995(一种抗HIV药物)增溶作用的影响:技术说明
AAPS PharmSciTech. 2004 Jul 27;5(3):e45. doi: 10.1208/pt050345.
10
Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.在无水多晶型物溶解过程中表面活性剂促进二水合卡马西平的结晶。
J Pharm Sci. 2004 Feb;93(2):449-60. doi: 10.1002/jps.10496.

甲磺酸氟哌啶醇在十二烷基硫酸钠存在下的溶液介导的相转变。

Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, 06269, USA.

出版信息

AAPS PharmSciTech. 2011 Sep;12(3):909-16. doi: 10.1208/s12249-011-9656-4. Epub 2011 Jul 6.

DOI:10.1208/s12249-011-9656-4
PMID:21732157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3167271/
Abstract

Forming a salt is a common way to increase the solubility of a poorly soluble compound. However, the solubility enhancement gained by salt formation may be lost due to solution-mediated phase transformation (SMPT) during dissolution. The SMPT of a salt can occur due to a supersaturated solution near the dissolving surface caused by pH or other solution conditions. In addition to changes in pH, surfactants are also known to affect SMPT. In this study, SMPT of a highly soluble salt, haloperidol mesylate, at pH 7 in the presence of a commonly used surfactant, sodium lauryl sulfate (SLS), was investigated. Dissolution experiments were performed using a flow-through dissolution apparatus with solutions containing various concentrations of SLS. Compacts of haloperidol mesylate were observed during dissolution in the flow-through apparatus using a stereomicroscope. Raman microscopy was used to characterize solids. The dissolution of haloperidol mesylate was significantly influenced by the addition of sodium lauryl sulfate. In conditions where SMPT was expected, the addition of SLS at low concentrations (0.1-0.2 mM) reduced the dissolution of haloperidol mesylate. In solutions containing concentrations of SLS above the critical micelle concentration (CMC) (10-15 mM), the dissolution of haloperidol mesylate increased compared to below the CMC. The solids recovered from solubility experiments of haloperidol mesylate indicated that haloperidol free base precipitated at all concentrations of SLS. Above 5 mM of SLS, Raman microscopy suggested a new form, perhaps the estolate salt. The addition of surfactant in solids that undergo solution-mediated phase transformation can add complexity to the dissolution profiles and conversion.

摘要

形成盐是提高难溶性化合物溶解度的常用方法。然而,盐形成带来的溶解度提高可能会由于溶解过程中的溶液介导的相转变(SMPT)而丧失。盐的 SMPT 可能由于溶解表面附近的过饱和溶液而发生,这是由 pH 或其他溶液条件引起的。除了 pH 的变化外,表面活性剂也已知会影响 SMPT。在这项研究中,研究了在常用表面活性剂十二烷基硫酸钠(SLS)存在下,pH 为 7 时高溶解度盐氟哌啶醇甲磺酸盐的 SMPT。使用包含各种 SLS 浓度的溶液在流通式溶解装置中进行溶解实验。使用立体显微镜在流通式装置中观察到氟哌啶醇甲磺酸盐在溶解过程中的片剂。拉曼显微镜用于对固体进行表征。加入十二烷基硫酸钠显著影响氟哌啶醇甲磺酸盐的溶解。在预期发生 SMPT 的条件下,低浓度(0.1-0.2mM)添加 SLS 会降低氟哌啶醇甲磺酸盐的溶解。在 SLS 浓度高于临界胶束浓度(CMC)(10-15mM)的溶液中,与 CMC 以下相比,氟哌啶醇甲磺酸盐的溶解增加。从氟哌啶醇甲磺酸盐溶解度实验回收的固体表明,在所有 SLS 浓度下都有游离氟哌啶醇碱沉淀。在 SLS 浓度高于 5mM 时,拉曼显微镜表明存在一种新的形式,可能是酯盐。在经历溶液介导的相转变的固体中添加表面活性剂会使溶解曲线和转化复杂化。